The relationship between plasminogen activator inhibitor-1 levels and the course of disease in COVID-19 patients

Abstract

Studies have shown that fibrinolysis activity is insufficient in COVID-19 patients. Plasminogen activator inhibitor-1 (PAI-1) is an important antifibrinolytic molecule that plays a key role in the fibrinolytic system. In our study; we aimed to evaluate serum PAI-1 and other biochemical parameters of COVID-19 patients in terms of disease course and mortality.

Keywords

• biochemical
• covid-19
• fibrinolysis
• mortality
• pai-1